- Dharmacon Screening libraries
- Human ON-TARGETplus 2.0 siRNA Libraries
Human ON-TARGETplus 2.0 siRNA Libraries
Generate hits that stand up to validation. ON-TARGETplus™ 2.0 siRNA libraries advance high throughput functional gene perturbation with highly potent and on-target gene knockdown through a combination of bioinformatic, formulation, and chemical design choices.
ON-TARGETplus 2.0 is built using the next-generation SMARTselection™ siRNA design algorithm that accounts for the diverse modern transcriptome. This is combined with the proprietary ON-TARGETplus dual-strand chemical modification strategy and optionally formulated in the unique siRNA SMARTpool™ format. The combination of these strategies results in multiple mechanisms to minimize off-target effects and ultimately generate high confidence successful hits in screening.
These siRNA libraries are available in collections spanning the human genome as well as key gene families and druggable collections; and are available in siRNA SMARTpools and set of four individual siRNA formats.
ON-TARGETplus™ 2.0 siRNA libraries
Gain confidence in your screening results by using reagents that reflect biologically relevant genomic data to reduce false positives/negatives. The next-generation RNAi SMARTselection algorithm and sequence curation method used in ON-TARGETplus 2.0 siRNA strives for optimal transcriptomic coverage and further reduced off-targets by considering current gene annotations. Combined with over two decades of experience in siRNA bioinformatic design and RNA chemical synthesis ON-TARGETplus 2.0 siRNA provides highly potent and on-target gene knockdown.
These collections provide a highly diverse set of reagents allowing interrogation of hundreds or thousands of genes with collections spanning the whole human genome, the druggable genome, and commonly studied gene families, providing flexible options for both focused and broad discovery in screening.
Flexibility in arrayed plating format and reagent formulation with siRNA pools or arrays of individual unique siRNA designs supports flexible screening approaches. Ultimately these collections provide the basis to support various single-well analytical techniques such as high content imaging, morphological profiling, reporter-based assays, and high throughput transcriptomics, supporting clear and interpretable data for high throughput screening using genetic perturbation with RNAi.
Highlights
See supporting data tab for data figures supporting the highlights below
- NEW in ON-TARGETplus 2.0 - Modernized transcriptome alignment & re-design: siRNAs are re-annotated and re-designed according to the latest transcriptome data for improved specificity. siRNAs are then curated so that individual siRNAs and SMARTpool siRNAs maximize transcript isoform coverage and ultimately minimize unintended off-targeting by avoiding newly annotated genes or changes in genomic coordinates.
- The proprietary dual-strand ON- TARGETplus chemical modification strategy employs two distinct mechanisms to reduce off- target effects
- Sense strand modification limits RISC loading and promotes selective antisense/active strand loading into the RISC.
- Antisense strand seed region is chemically modified to destabilize microRNA-like off-target activity and enhance target specificity.
- Available as siRNA SMARTpool reagents which minimize individual siRNA seed-mediated off-target signatures through dilution while maintaining potent on-target knockdown.
- Bioinformatic design excludes known seed regions that occur frequently in the genome and selects for low-frequency designs for siRNA to reduce off-targeting.
- Available in 96 or 384-well plate formats. Echo acoustic dispensing compatible plates available upon request.
- Arrayed with space to allow spiking of reagents for controls on each plate.
- Also available as siRNA cherry pick libraries for custom gene selection and hit follow-up efforts.
Available pre-defined collections and approximate gene counts:
Please note, the whole genome library contains the Druggable Genome collection which contains 8 discrete sub-collections, and all remaining protein coding genes annotated in the relevant reference genome.
| Human ON-TARGETplus 2.0 siRNA libraries | Approximate number of genes |
|---|---|
| Whole Genome | 19,600 |
| Druggable Genome | 7,830 |
| GPCRs | 470 |
| Ion Channels | 420 |
| Phosphatases | 310 |
| Proteases | 690 |
| Protein Kinases | 760 |
| Ubiquitin Enzymes | 760 |
| Transcription Factors | 1,570 |
| Drug Targets | 3,300 |
| Ubiquitin Conjugation Subset 1 | 90 |
| Ubiquitin Conjugation Subset 2 | 110 |
| Ubiquitin Conjugation Subset 3 | 390 |
| Apoptosis | 550 |
| Cell Cycle Regulation | 170 |
| Cytokine Receptors | 140 |
| Deubiquitinating Enzymes | 110 |
| DNA Damage Response | 240 |
| Epigenetics | 850 |
| Membrane Trafficking | 140 |
| Nuclear Receptors | 50 |
| Tyrosine Kinases | 90 |
"The light blue shading collections represents part of druggable genome"
Library gene lists
For a complete list of target genes in each siRNA library, please contact Scientific Support.
Our siRNA knockdown guarantee
ON-TARGETplus 2.0 siRNA reagents (SMARTpool siRNA and three out of four individual siRNAs) are guaranteed to silence target gene expression by at least 75% at the mRNA level compared to non-targeting controls as measured by qPCR when demonstrated to have been used under optimal delivery conditions (confirmed using functionally validated positive control and measured at 24 to 72 hours after transfection using 100 nM siRNA).
Note: While we guarantee knockdown >75% at 100 nM, most ON-TARGETplus 2.0 siRNA products are highly functional at 5-25 nM working concentration. Titration is recommended to maximize on-target siRNA effect and minimize any off-target behavior. Optimal siRNA delivery conditions and working concentration are experiment specific.
Gene perturbation in screening: ON-TARGETplus 2.0 siRNA reagents are guaranteed to knock down under optimal conditions; in a screening setting target knockdown is subject to the screening approach. This includes factors such as the model system appropriately expressing the target mRNA, optimization of siRNA delivery and timing of delivery across various experimental conditions, and appropriate analytical endpoints. It can be challenging to de-convolute multiple contributing variables for a negative hit (no knockdown); and ultimately different targets may require different conditions. The Dharmacon reagents team is here to support your scientific efforts and is happy to consult on negative hit follow-up to try and determine conditions that may improve results for individual targets.
Please reach out to our technical support team for any questions or for guidance on optimizing the use of your siRNA products.
Complete your knockdown experiment by adding these supporting reagents to your order
ON-TARGETplus 2.0 siRNA controls
Validated positive controls and non-targeting negative controls designed for use with next-generation ON-TARGETplus 2.0 siRNAs. Featuring proprietary ON-TARGETplus synthetic modifications for superior specificity and minimized off-target effects. Available as pooled or single siRNAs.
ON-TARGETplus 2.0 control siRNAs deliver improved specificity, reduced seed-based off-targeting, and enhanced consistency across experiments. These controls are recommended for any siRNA workflow utilizing ON-TARGETplus 2.0 reagents. Pooled siRNA controls are recommended when additional off-target reduction is desired and are ideal for use alongside ON-TARGETplus 2.0 pooled siRNA reagents.
Select relevant positive controls to efficiently silence a robustly expressed housekeeping gene in your experimental system for confidence in your reagents function.
| ON-TARGETplus 2.0 Positive Control Reagents | Species | Catalog Number |
|---|---|---|
| ON-TARGETplus 2.0 Cyclophilin B Control siRNA | Human | D2-001820-01 |
| Mouse | D2-001820-02 | |
| Rat | D2-001820-03 | |
| ON-TARGETplus 2.0 Cyclophilin B Control Pool | Human | D2-001820-10 |
| Mouse | D2-001820-20 | |
| Rat | D2-001820-30 | |
| ON-TARGETplus 2.0 GAPD Control siRNA | Human | D2-001830-01 |
| Mouse | D2-001830-02 | |
| ON-TARGETplus 2.0 GAPD Control Pool | Human | D2-001830-10 |
| Mouse | D2-001830-20 | |
| ON-TARGETplus 2.0 Negative Control Reagents | Species | Catalog Number |
| ON-TARGETplus 2.0 Non-targeting siRNAs | Human, Mouse, Rat | D2-001810-0X |
| ON-TARGETplus 2.0 Non-targeting Pool | Human, Mouse, Rat | D2-001810-10 |
Transfection reagents
DharmaFECT transfection reagents are optimized for improved delivery and reduced toxicity. Different formulations of DharmaFECT are available to optimize delivery for your experimental system. The best DharmaFECT reagent for your experiment will depend on your cell type.
Composition of Whole Genome and Druggable Genome libraries
ON-TARGETplus 2.0 siRNA libraries are available as smaller stand-alone collections curated by gene family or grouped mechanistically. The Whole Genome library is comprised of the Druggable Genome and all remaining currently annotated protein-coding genes. The Druggable Genome is a combination of Drug Targets and 7 other curated sub-collections; some redundancy occurs between collections when genes fall in multiple categories (for example, Drug Targets and Protein Kinases).
ON-TARGETplus 2.0 and siRNA SMARTpool supporting data:
ON-TARGETplus 2.0 siRNA achieves high knockdown efficiency with superior mitigation of off-targeting in U2OS cells
U2OS cells were transfected with 25 nM of four individual ON-TARGETplus 2.0 siRNAs and 25 nM of the ON-TARGETplus 2.0 siRNA SMARTpool along with three competitor siRNA designs targeting TP53 using vendor recommended concentrations and procedures. TP53 expression was measured via qPCR and number of unique off targets associated with each condition assessed via RNAseq. All siRNAs achieved high knockdown efficiency, but two out of three competitor designs were associated with hundreds of unique off-targets. Additionally, siRNA SMARTpool exhibits a superior off-target profile similar to optimal individual designs as expected due to lower concentrations of each individual siRNA in the pool vs individual conditions.
Competitive benchmarking experiments highlight potent target knockdown with consistently minimal off-targeting using ON-TARGETplus 2.0 siRNA SMARTpools compared to competitor siRNA designs
U2OS cells were transfected with 25 nM of four individual ON-TARGETplus 2.0 siRNAs (not shown) and 25 nM of the ON-TARGETplus 2.0 siRNA SMARTpools along with three competitor siRNA designs targeting per target (BUB1, BRD2, and DUSP1) using vendor recommended concentrations and procedures. Gene expression was measured via qPCR and number of unique off targets associated with each condition assessed via RNAseq. In all experiments, ON-TARGETplus 2.0 siRNA SMARTpools produced potent gene knockdown with consistently lower unique off-targets compared to competitor designs.
ON-TARGETplus 2.0 siRNA mitigates newly discovered off-target effects arising from reference genome transcriptome expansion

U2OS or HEK293T cells were transfected with 25 nM ON-TARGETplus or ON-TARGETplus 2.0 siRNAs targeting the YY1AP1 gene, or a non-targeting control (NTC) siRNA with 0.2 µL/well DharmaFECT 1 transfection reagent (HEK293T) or DharmaFECT 4 transfection reagent (U2OS). After 48 hours, total RNA was isolated and prepped for RNAseq or RT-qPCR. A. Data plotted as a histogram showing the distribution of global transcriptional expression in U2OS cells, represented as transcripts per million (TPM). Strong downregulation of YY1AP1 mRNA expression was observed in all four siRNA treatment groups, denoted on the x-axis and represented as log2 transformed TPM fold change while global gene expression was largely unchanged relative to the corresponding NTC siRNA. Notably, ON-TARGETplus siRNAs also depleted expression of the off-target gene GON4L whereas ON-TARGETplus 2.0 siRNAs maintained high specificity and did not affect GON4L expression. n = 2 biologically independent samples per group. B. Relative gene expression was measured using RT-qPCR. The relative expression of each gene was calculated with the ∆∆Cq method using ACTB as the housekeeping gene and normalized to an NTC. Robust target gene knockdown was observed with both ON-TARGETplus and ON-TARGETplus 2.0 siRNAs, however, the ON-TARGETplus siRNA was found to also reduce expression of an off-target gene, GON4L. The ON-TARGETplus 2.0 siRNAs maintained high specificity and did not affect GON4L expression. n = 2 biologically independent samples per group.
Supporting Data for ON-TARGETplus siRNA dual-strand chemical modifications, the original SMARTselection algorithm, and siRNA SMARTpool format:
ON-TARGETplus siRNA chemical modifications reduce the overall number of off-targets and pooling reduces them even further
Panels (A) and (B) are representative examples of off-target signatures with and without application of ON-TARGETplus modifications to (A) a single siRNA and (B) a SMARTpool reagent. Green bars indicate genes with 2-fold or more reduction of expression when treated with the indicated siRNA reagent.The ON-TARGETplus modifications reduced the off-targets when compared to unmodified siRNA. Pooling of siRNA and the ON-TARGETplus modification pattern independently, and in combination, provide significant reduction in off-target gene silencing. Panel (C) represents quantitation of off-targets (down-regulated by 2-fold or more) induced by the indicated siRNA reagents targeting 10 different genes (4 siRNAs per gene or a single SMARTpool reagent). Off-targets were quantified using microarray analysis (Agilent) then compiled. Each shaded box represents the middle 50% of the data set. Horizontal line in box: Median value of the data set. Vertical bars: minimum and maximum data values.
False phenotypes due to off-targets are alleviated by ON-TARGETplus SMARTpool reagents while target gene knockdown is maintained
The effect of silencing ARPC1B on cell migration was studied in a breast cancer cell line. A monolayer of cells was uniformly scraped and the rate of cell migration to close the scrape (wound healing) was evaluated. Both unmodified and ON-TARGETplus siRNA reagents induced potent target knockdown. Inconsistent phenotypes due to off-target effects (red outline), were observed for cells transfected with unmodified individual siRNAs. The unmodified SMARTpool siRNAs improved the false phenotype considerably, while the ON-TARGETplus SMARTpool siRNAs significantly reduced off-target effects to produce a consistent phenotype.
In collaboration with Kaylene Simpson, Laura Selfors, and Joan Brugge, Harvard Medical School.
Only the ON-TARGETplus modification pattern addresses both siRNA strands for premium silencing
The ON-TARGETplus dual-strand chemical modification begins with the sense (passenger) strand being blocked from RISC uptake to favor antisense (guide) strand loading and reduce passenger strand-induced off-targets. However, the majority of siRNA off-targets are driven by the seed region of the guide strand. ON-TARGETplus siRNA is modified within its seed region to destabilize miRNA-like activity and improve specificity to the desired target for potent knockdown.
SMARTselection algorithmic design of siRNA with low-frequency seed regions ensure fewer off-targets

ON-TARGETplus siRNA designs leverage sophisticated bioinformatics to reduce the likelihood of miRNA-like off-targets from high-frequency or highly conserved miRNA seed regions. siRNAs with low seed frequency have a significantly lower number of off-targets than siRNAs with medium or high frequency seeds. Five siRNAs with low, medium, or high frequency seed regions were transfected into HeLa cells and their associated off-target signatures assessed via global expression profiling (Agilent 22K platform). siRNA sequences were constant at positions 1 and 8-19, only the seed regions (positions 2-7) were altered.
Low frequency seeds: < 350 occurrences in the HeLa transcriptome
Medium frequency: 2500-2800 occurrences
High frequency: >3800 occurrences
The Dharmacon Reagents team has a suite of webtools for product configuration and calculators to make your experiments easier. View some of our screener-friendly calculators below to determine quantities of siRNA or volumes of DharmaFECT transfection reagent required for your experiments:
Reagent calculators for screening:
View our Ordering and calculation tools webpage for all of our convenient webtools and calculators.
- B.D. Parsons, A. Schindler, D.H. Evans, E. Foley, A direct phenotypic comparison of siRNA pools and multiple individual duplexes in a functional assay. PLoS One. 4(12), e8471 (2009).
- M. Jiang, R. Instrell, B. Saunders, H. Berven, M. Howell, Tales from an academic RNAi screening facility; FAQs. Brief Funct. Genomics. 10(4), 227-237 (2011). [doi: 10.1093/bfgp/elr016]
- J. Borawski, A. Lindeman, F. Buxton, M. Labow, L.A. Gaither, Optimization procedure for small interfering RNA transfection in a 384-well format. J. Biomol. Screen. 12(4), 546-559 (2007).
- T. Ratovitski, E. Chighladze, E. Waldron, R. R. Hirschhorn, C. A. Ross, Cysteine proteases bleomycin hydrolase and cathepsin Z mediate N-terminal proteolysis and toxicity of mutant huntingtin. J. Biol. Chem. 286(14), 12578-12589 (2011). [Human Proteases]
Product inserts
Protocols
Safety data sheets
Related Products
Negative control pool of four siRNAs designed and microarray tested for minimal targeting of human, mouse or rat genes. ON-TARGETplus modifications reduce potential off-targets. Recommended for determination of baseline cellular responses in RNAi experiments.
Concentrated buffer solution recommended for resuspension and long-term storage of any short, double-strand, or single-strand synthetic RNA molecule. Dilute with RNase-free water prior to use.
Molecular grade water for dilution of 5x siRNA Buffer or resuspension of RNA. RNase-free to prevent degradation of RNA reagents and oligonucleotides.
An aliquot of each of the four DharmaFECT formulations for siRNA/microRNA transfection optimization studies